MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-25-2026
TELA Bio Cash Conversion Cycle 2011-2026 | TELA
Annual Cash Conversion Cycle TELA Bio
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 185 | 232 | 272 | 256 | 193 | 183 | 152 | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 272 | 152 | 210 |
Quarterly Cash Conversion Cycle TELA Bio
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 179 | 195 | 206 | - | 217 | - | - | - | 279 | 282 | 286 | - | 232 | 216 | 189 | - | 152 | 171 | 179 | - | 198 | 290 | 215 | - | 166 | 177 | 132 | - | 81.8 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 290 | 81.8 | 202 |
Cash Conversion Cycle of other stocks in the Medical devices industry
| Issuer | Cash Conversion Cycle | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BioSig Technologies
BSGM
|
607 | - | 37.08 % | $ 85.7 M |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
104 | - | - | $ 1.77 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
299 | - | - | $ 3.31 B | USA |
 |
Lianluo Smart Limited
LLIT
|
94.1 | - | 24.59 % | $ 44.8 M |  China |
 |
Dynatronics Corporation
DYNT
|
80.5 | - | 14.99 % | $ 929 K | USA |
 |
Aziyo Biologics
AZYO
|
-81.2 | - | 1.37 % | $ 20.5 M | USA |
 |
Acutus Medical
AFIB
|
761 | - | -26.83 % | $ 2.62 M | USA |
 |
Allied Healthcare Products
AHPI
|
271 | - | 3.58 % | $ 2.21 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
174 | - | -5.86 % | $ 30.6 M | USA |
 |
Align Technology
ALGN
|
137 | $ 166.38 | -6.17 % | $ 12.5 B | USA |
 |
Bruker Corporation
BRKR
|
227 | $ 33.72 | -4.58 % | $ 5.02 K | USA |
 |
Alphatec Holdings
ATEC
|
240 | $ 10.93 | -5.12 % | $ 1.64 B | USA |
 |
ClearPoint Neuro
CLPT
|
217 | $ 9.07 | -3.41 % | $ 257 M | USA |
 |
Conformis
CFMS
|
165 | - | - | $ 16.4 M | USA |
 |
Accuray Incorporated
ARAY
|
184 | $ 0.4 | 4.21 % | $ 41.1 M | USA |
 |
Abbott Laboratories
ABT
|
101 | $ 103.99 | -0.55 % | $ 181 B | USA |
 |
Cardiovascular Systems
CSII
|
172 | - | 0.15 % | $ 844 M | USA |
 |
Second Sight Medical Products
EYES
|
-29.6 | - | -0.97 % | $ 54.4 M | USA |
 |
Apollo Endosurgery
APEN
|
156 | - | - | $ 475 M | USA |
 |
Electromed
ELMD
|
180 | $ 24.55 | 0.16 % | $ 208 M | USA |
 |
Boston Scientific Corporation
BSX
|
107 | $ 69.17 | -1.43 % | $ 102 B | USA |
 |
Avinger
AVGR
|
335 | - | -20.74 % | $ 369 K | USA |
 |
CryoLife, Inc.
CRY
|
183 | - | -4.14 % | $ 702 M | USA |
 |
Establishment Labs Holdings
ESTA
|
339 | $ 55.31 | -7.68 % | $ 1.64 B |  Costa-rica |
 |
CONMED Corporation
CNMD
|
212 | $ 34.58 | -5.7 % | $ 1.07 B | USA |
 |
Soliton, Inc.
SOLY
|
-67.9 | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
9.86 | - | -1.98 % | $ 98.3 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
-227 | - | 0.03 % | $ 1.58 B |  Israel |
 |
NanoVibronix
NAOV
|
853 | - | - | $ 1.08 M | USA |
 |
Misonix, Inc.
MSON
|
28.8 | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
81.2 | - | - | $ 111 M |  Canada |
 |
Intersect ENT, Inc.
XENT
|
45.4 | - | - | $ 955 M | USA |
 |
Cytosorbents Corporation
CTSO
|
50.6 | $ 0.59 | -1.18 % | $ 32.1 M | USA |
 |
Aethlon Medical
AEMD
|
-61.8 | $ 2.15 | -5.29 % | $ 3.36 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
283 | $ 79.34 | -3.36 % | $ 46.4 B | USA |
 |
BIOLASE
BIOL
|
129 | - | -13.19 % | $ 166 K | USA |
 |
Helius Medical Technologies
HSDT
|
18.2 | $ 1.92 | -4.48 % | $ 1.17 M | USA |
 |
IRIDEX Corporation
IRIX
|
119 | $ 0.99 | -26.67 % | $ 16 M | USA |
 |
IRadimed Corporation
IRMD
|
224 | $ 97.36 | -1.4 % | $ 1.24 B | USA |
 |
Integer Holdings Corporation
ITGR
|
96.8 | $ 85.33 | -1.73 % | $ 2.96 B | USA |
 |
AdaptHealth Corp.
AHCO
|
20.1 | $ 11.2 | -1.84 % | $ 1.51 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
714 | $ 15.52 | -5.08 % | $ 364 M | USA |
 |
Invacare Corporation
IVC
|
214 | - | - | $ 24.7 M | USA |
 |
Ra Medical Systems
RMED
|
-1.22 K | - | 10.0 % | $ 610 K | USA |
 |
Myomo
MYO
|
82.3 | $ 0.7 | 2.32 % | $ 29.3 M | USA |
 |
Penumbra
PEN
|
352 | $ 335.1 | -0.39 % | $ 13 B | USA |
 |
Inspire Medical Systems
INSP
|
248 | $ 50.13 | -0.54 % | $ 1.47 B | USA |
 |
Pulmonx Corporation
LUNG
|
246 | $ 1.17 | -5.65 % | $ 47.6 M | USA |
 |
Cutera
CUTR
|
404 | - | -10.19 % | $ 1.99 M | USA |